Literature DB >> 21624820

Autoantibodies with enzymatic properties in human autoimmune diseases.

Bharath Wootla1, Sébastien Lacroix-Desmazes, Arthur E Warrington, Allan J Bieber, Srini V Kaveri, Moses Rodriguez.   

Abstract

Immunoglobulins (Ig) or antibodies are heavy plasma proteins, with sugar chains added to amino acid residues by N-linked glycosylation and occasionally by O-linked glycosylation. The versatility of antibodies is demonstrated by the various functions that they mediate such as neutralization, agglutination, fixation with activation of complement and activation of effector cells. In addition to this plethora of functions, some antibodies express enzymatic activity. Antibodies endowed with enzymatic properties have been described in human autoimmune manifestations in a variety of disorders such as autoimmune thyroiditis, systemic erythematosus (SLE), scleroderma, rheumatoid arthritis (RA), multiple sclerosis (MS) and acquired hemophilia (AH). Antibodies isolated from these conditions were able to specifically hydrolyze thyroglobulin, DNA, RNA, myelin basic protein (MBP), and factor VIII (FVIII) or factor IX (FIX), respectively. The therapeutic relevance of these findings is discussed.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21624820      PMCID: PMC3173522          DOI: 10.1016/j.jaut.2011.05.007

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  79 in total

1.  Autoantibodies to nuclear antigens: correlation between cytotoxicity and DNA-hydrolyzing activity.

Authors:  A V Kozyr; A V Kolesnikov; N A Zelenova; L P Sashchenko; S V Mikhalap; M E Bulina; A N Ignatova; P V Favorov; A G Gabibov
Journal:  Appl Biochem Biotechnol       Date:  2000 Jan-Mar       Impact factor: 2.926

Review 2.  Epigenetics in autoimmune disorders: highlights of the 10th Sjögren's syndrome symposium.

Authors:  Qianjin Lu; Yves Renaudineau; Seunghee Cha; Gabor Ilei; Wesley H Brooks; Carlo Selmi; Athanasios Tzioufas; Jacques-Olivier Pers; Stefano Bombardieri; M Eric Gershwin; Steffen Gay; Pierre Youinou
Journal:  Autoimmun Rev       Date:  2010-05-07       Impact factor: 9.754

3.  High levels of catalytic antibodies correlate with favorable outcome in sepsis.

Authors:  Sébastien Lacroix-Desmazes; Jagadeesh Bayry; Srini V Kaveri; David Hayon-Sonsino; Nithyananda Thorenoor; Julien Charpentier; Charles-Edouard Luyt; Jean-Paul Mira; Valakunja Nagaraja; Michel D Kazatchkine; Jean-François Dhainaut; Vincent O Mallet
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-02       Impact factor: 11.205

4.  Chemical achievement and hope for the future.

Authors:  L PAULING
Journal:  Am Sci       Date:  1948-01       Impact factor: 0.548

5.  Polyclonal antibodies from blood and cerebrospinal fluid of patients with multiple sclerosis effectively hydrolyze DNA and RNA.

Authors:  A G Baranovskii; T G Kanyshkova; A S Mogelnitskii; V A Naumov; V N Buneva; E I Gusev; A N Boiko; T A Zargarova; O O Favorova; G A Nevinsky
Journal:  Biochemistry (Mosc)       Date:  1998-11       Impact factor: 2.487

6.  The odd couple: a fresh look at autoimmunity and immunodeficiency.

Authors:  Ian R Mackay; Natasha V Leskovsek; Noel R Rose
Journal:  J Autoimmun       Date:  2010-09-06       Impact factor: 7.094

7.  Acquired factor IX deficiency. A report of two cases.

Authors:  S Ozsoylu; F L Ozer
Journal:  Acta Haematol       Date:  1973       Impact factor: 2.195

8.  Geo-epidemiology and autoimmunity.

Authors:  Pierre Youinou; Jacques-Olivier Pers; M Eric Gershwin; Yehuda Shoenfeld
Journal:  J Autoimmun       Date:  2009-12-28       Impact factor: 7.094

9.  A survey of 215 non-hemophilic patients with inhibitors to Factor VIII.

Authors:  D Green; K Lechner
Journal:  Thromb Haemost       Date:  1981-06-30       Impact factor: 5.249

10.  Alzheimer's disease: a pathogenetic autoimmune disorder caused by herpes simplex in a gene-dependent manner.

Authors:  C J Carter
Journal:  Int J Alzheimers Dis       Date:  2010-12-29
View more
  7 in total

1.  Maternal immune-mediated conditions, autism spectrum disorders, and developmental delay.

Authors:  Kristen Lyall; Paul Ashwood; Judy Van de Water; Irva Hertz-Picciotto
Journal:  J Autism Dev Disord       Date:  2014-07

Review 2.  Need for a paradigm shift in therapeutic approaches to CNS injury.

Authors:  Bharath Wootla; Aleksandar Denic; Arthur E Warrington; Moses Rodriguez
Journal:  Expert Rev Neurother       Date:  2012-04       Impact factor: 4.618

3.  Constant domain-regulated antibody catalysis.

Authors:  Gopal Sapparapu; Stephanie Planque; Yukie Mitsuda; Gary McLean; Yasuhiro Nishiyama; Sudhir Paul
Journal:  J Biol Chem       Date:  2012-09-04       Impact factor: 5.157

4.  Deoxyribonuclease activity of polyclonal IgGs: a putative serological marker in patients with spondyloarthritides.

Authors:  Alena V Kundzer; Margarita V Volkova; Dimitrios P Bogdanos; Stefan Rödiger; Peter Schierack; I Generalov; Georgy A Nevinsky; Dirk Roggenbuck
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

Review 5.  Autoimmunity in 2011.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2012-08       Impact factor: 8.667

6.  Catalytic antibodies in patients with systemic lupus erythematosus.

Authors:  Vandana Pradhan; Pallavi Pandit; Prathamesh Surve; Maxime Lecerf; Anjali Rajadhyaksha; Milind Nadkar; Prasad V Khadilkar; Durga A Chougule; Aalaap A Naigaonkar; Sébastien Lacroix-Desmazes; Jagadeesh Bayry; Kanjaksha Ghosh; Srini V Kaveri
Journal:  Eur J Rheumatol       Date:  2018-08-07

7.  Beyond new chemical entities: advancing drug development based on functional versatility of antibodies.

Authors:  Salvador Eugenio C Caoili
Journal:  Hum Vaccin Immunother       Date:  2014-03-14       Impact factor: 3.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.